Cipla hits 52-week high ahead of Q1 nos

The stock ended at Rs 268 - up 2.3%. The counter witnessed comparatively heavy volumes of around 422,550 shares on the BSE today.
___________________________________________________
(Updated at 1328hrs)

Cipla today rallied to a 52-week high of Rs 270 ahead of its Q1 results this Wednesday. The stock has now advanced 2.5% to Rs 268.

The counter has witnessed trades of 306,525 shares, which is significantly more than its two-week average traded volume of 226,500 shares on the BSE.

Recently, Cipla received demand notices from the Supreme Court.  The company has been slapped with a fine of Rs 64.39 crore and  Rs 2.19 crore in respect of the drug Salbutamol  and Norfloxacin by the National Pharmaceutical Pricing Authority, Government of India.